Clinical studies have proven that screening for certain cancers and heart disease saves lives. But questions linger. Will those screened derive any mortality benefit? If so, how great is it? What is the cost relative to gains, relative to treatment costs? This month were drilling down into CT screening, for lung cancer, colorectal cancer and coronary artery disease. There are still more questions than answers, but studies are underway.